×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2026半年會
摘要
2025年會 (UAA)
摘要
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
最新上傳
最新上傳
(
熱門
)
最新上傳
(
熱門
)
#0657 Comparative Analysis of Graft Options for Urethral Stricture: Implications for Qmax, Erectile Dysfunction, and Quality of Life: A Systematic Review and Meta Analysis
04-23
#0600 To Drain or not to Drain? Surgical Decision Making in Prostate Abscess
04-23
#0460 Bacterial Vaccines for Preventing Recurrent Urinary Tract Infections: A Systematic Review and Meta-Analysis
04-23
#0439 Management of Self-Inserted Foreign Bodies in the Lower Urinary Tract: A Case Series and Literature Review
04-23
#0430 Risk of cystoscopy-related urinary tract infections with Pseudomonas aeruginosa
04-23
#0219 Insufficient S-sulfhydration of cAMP-response element binding protein participates in kidney fibrosis via promoting epithelial-mesenchymal transition
04-23
#0155 Histological features suggestive of survival in patients with renal cell carcinoma and tumor thrombus: A singlecenter experience
04-23
#0144 Salinomycin inhibits SREBP1 to sensitizes ferroptosis and ameliorate sorafenib resistance in clear cell renal cell carcinoma
04-23
#0115 Role of Relook Flexible Ureteroscopy in Post-Stenting Management of Acute Pyelonephritis: Where We Miss the Boat
04-23
#0114 National Early Warning Score 2 (NEWS2) and Quick Sequential Organ Failure Assessment (qSOFA) Score in Acute Pyelonephritis: Tools for Expedited Care and Improved Outcomes
04-23
#0098 Construction of a predictive model for pT3a risk in cT1 renal cell carcinoma using perioperative characteristics: a comparison of various machine learning techniques with adaptive synthetic sampling
04-23
#0096 Predictors of Hemorrhage after Partial Nephrectomy for Stage T1 Renal Cell Carcinoma: 10-year Experience from a Regional Medical Center in Eastern China
04-23
#1311 Nano-Ni0 nanocatalysts disrupt redox homeostasis via hydrogen-induced reductive stress and nickel-driven chemodynamic therapy for bladder cancer treatment and immune modulation
04-23
#1273 Hyperthermia Intravesical Chemotherapy vs. Bacillus Calmette-Guérin instillation and Mitomycin C Perfusion for Non-muscle-invasive Bladder Cancer: A Network Meta-analysis
04-23
#0812 Infrapubic Foley catheter balloon tamponade for retropubic venous haemorrhage during radical cystoprostatectomy and urethrectomy
04-23
#0411 Effect of statin use on outcomes of non-muscle-invasive bladder cancer: a systematic review and meta-analysis
04-23
#0406 The comparison of robotic-assisted and laparoscopic radical nephroureterectomy in non-metastatic upper tract urothelial carcinoma
04-23
#0371 The use patient-derived prostate cancer organoids as a tool to predict response to therapy
04-23
#0362 Comprehensive Bioinformatics Approach for Identifying Lipid-Related Markers in Bladder Cancer Prognosis
04-23
#0298 CD163+ Tumor-Associated Macrophages and GATA3 Expression: Promising Markers for Predicting Post-Surgery Progression in Locally Advanced Upper Tract Urothelial Carcinoma
04-23
#0295 Enhancing Individual Survival Prediction in Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy Using Machine and Deep Learning AI models
04-23
#0221 Treatment of Muscle Invasive Bladder Cancer in the Elderly: A systematic review and meta-analysis
04-23
#0216 Anemia is associated with inferior outcomes in non-muscle invasive bladder cancer patients receiving Bacillus Calmette-Guérin immunotherapy
04-23
#0215 META-ANALYTICAL ASSESSMENT ABOUT STANDARD AND EXTENDED PELVIC LYMPH NODE DISSECTION IN TERMS OF POST-OPERATIVE COMPLICATIONS IN PATIENTS UNDER RADICAL CYSTECTOMY
04-23
<
18
19
20
21
22
23
24
25
26
27
>
/ 155